Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors

Y Ueki, H Otsuka, T Otani, R Kasai, Y Otomi… - Japanese Journal of …, 2024 - Springer
Purpose Somatostatin receptor scintigraphy (SRS) using 111In-DTPA-DPhe1-octreotide
(pentetreotide) has become an integral part of neuroendocrine neoplasm management. The …

[引用][C] Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors

Y Ueki, H Otsuka, T Otani, R Kasai, Y Otomi… - Japanese Journal of …, 2024 - cir.nii.ac.jp
Combined visual and quantitative assessment of somatostatin receptor scintigraphy for
staging and restaging of neuroendocrine tumors | CiNii Research CiNii 国立情報学研究所 学術 …

Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.

Y Ueki, H Otsuka, T Otani, R Kasai, Y Otomi… - Japanese Journal of …, 2024 - europepmc.org
Somatostatin receptor scintigraphy (SRS) using 111In-DTPA-DPhe1-octreotide
(pentetreotide) has become an integral part of neuroendocrine neoplasm management. The …

Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors

Y Ueki, H Otsuka, T Otani, R Kasai… - … journal of radiology, 2024 - pubmed.ncbi.nlm.nih.gov
Purpose Somatostatin receptor scintigraphy (SRS) using 111 In-DTPA-DPhe 1-octreotide
(pentetreotide) has become an integral part of neuroendocrine neoplasm management. The …

Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors

Y Ueki, H Otsuka, T Otani, R Kasai… - Japanese Journal …, 2024 - repo.lib.tokushima-u.ac.jp
Purpose: Somatostatin receptor scintigraphy (SRS) using 111In-DTPA-DPhe1-octreotide
(pentetreotide) has become an integral part of neuroendocrine neoplasm management. The …

Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors

Y Ueki, H Otsuka, T Otani, R Kasai… - Japanese Journal …, 2024 - repo.lib.tokushima-u.ac.jp
Purpose: Somatostatin receptor scintigraphy (SRS) using 111In-DTPA-DPhe1-octreotide
(pentetreotide) has become an integral part of neuroendocrine neoplasm management. The …